Insider · CIK 0001619259
Jonathan Schechter
Files at TWAV (Oblong, Inc.), PMCB (PharmaCyte Biotech, Inc.), TAOX (TAO Synergies Inc.). First filing Sep 16, 2025, latest Jan 7, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
TWAV: Oblong, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
PMCB: PharmaCyte Biotech, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | PharmaCyte Biotech, Inc. | $48k 60,000 shares | +45% | - | |
| 38Weak | Oblong, Inc. | $19k 10,000 shares | +67% | - | |
| 38Weak | Oblong, Inc. | $13k 5,000 shares | +50% | - | |
| 36Weak | Oblong, Inc. | $27k 10,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | PMCB PharmaCyte Biotech, Inc. | POpen-market purchase Common Stock | +20,000 | $0.78 | $16k | 152,500 | Jan 7, 2026 |
| Jan 6, 2026 | PMCB PharmaCyte Biotech, Inc. | POpen-market purchase Common Stock | +20,000 | $0.79 | $16k | 172,500 | Jan 7, 2026 |
| Jan 7, 2026 | PMCB PharmaCyte Biotech, Inc. | POpen-market purchase Common Stock | +20,000 | $0.84 | $17k | 192,500 | Jan 7, 2026 |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 200,000 | Dec 12, 2025 |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc. | FTax withholding Common Stock | -67,500 | $1.02 | $69k | 132,500 | Dec 12, 2025 |
| Apr 25, 2025 | PMCB PharmaCyte Biotech, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +63,233 | $0.00 | $0 | 63,233 | Dec 12, 2025 |
| Nov 14, 2025 | TWAV Oblong, Inc. | POpen-market purchase COMMON STOCK | +10,000 | $1.91 | $19k | 25,000 | Nov 17, 2025 |
| Aug 6, 2025 | TAOX TAO Synergies Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Oct 17, 2025 |
| Sep 17, 2025 | TWAV Oblong, Inc. | POpen-market purchase COMMON STOCK | +5,000 | $2.70 | $13k | 15,000 | Sep 17, 2025 |
| Sep 16, 2025 | TWAV Oblong, Inc. | POpen-market purchase COMMON STOCK | +10,000 | $2.73 | $27k | 10,000 | Sep 16, 2025 |
| Jun 30, 2025 | TAOX TAO Synergies Inc. | AGrant or award Common Stock, par value $0.0001 per share | +21,575 | $0.00 | $0 | 22,665 | Jul 2, 2025 |
| Jun 30, 2025 | TAOX TAO Synergies Inc. | FTax withholding Common Stock, par value $0.0001 per share | -8,630 | $7.85 | $68k | 14,035 | Jul 2, 2025 |
| Apr 3, 2025 | TAOX TAO Synergies Inc. | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.